Find an expert

Lisa Akison is a Senior Lecturer in the School of Biomedical Sciences (SBMS) at the University of Queensland. She has conducted research using rodent models for over 30 years and has been a reproductive biologist since 2005. She completed her PhD (2013) and early Post-doctoral training at the Robinson Institute, University of Adelaide, where she examined the molecular regulation of ovulation and oviductal function. Following her move to UQ in 2015, her research focussed on the developmental origins of health and disease, where she examined developmental programming of various organs and physiological processes. In particular, she has examined the impact of prenatal alcohol exposure, examining impacts on the embryo, fetus and adult offspring. She is also interested in the role that the placenta plays in mediating these effects.

Lisa received training in systematic review and meta-analysis methodology in 2016 and has since published systematic reviews on diverse topics in child and infant health. She now teaches critical appraisal of clinical studies and systematic review methodology to 3rd year biomedical science students, as well as endocrinology, physiology and histology. She has research interests in the Scholarship of Teaching and Learning, and is a current member of the Biomedical Education Research Group at SBMS.

Stephen is a physiologist with expertise in endocrinology and student learning. His research examines the hormonal control of growth, metabolism, appetite, and reproduction - unravelling how hormones regulate physiological mechanisms in healthy individuals versus dysfunction that occurs in disease states. Stephen is also interested in metacognition of learning, self-regulation of learning, and lifelong learning. He is currently investigating how students develop capabilities during their undergraduate studies to support their future professional roles.

Stephen held the position of Director of Teaching and Learning in the School of Biomedical Sciences at UQ from 2019 to 2024, and holds Graduate Certificates in Higher Education (University of Queensland, 2013) and Tertiary Education Management (University of Melbourne, 2023). In 2020 he was awarded Academic Leader of the Year in the UQ Faculty of Medicine. Stephen has taught physiology to about 40,000 UQ students across science, biomedical science, animal and veterinary sciences, health science, exercise science, human movement and nutrition science, dentistry, pharmacy, speech pathology, physiotherapy, occupational therapy, and medical doctor programs.

Dr Cuffe is a systems physiologist focused on understanding the complex changes to maternal physiology that occur during pregnancy and the impact of pregnancy dysfunction of programmed cardiovascular, metabolic and renal disease in offspring. Dr Cuffe has a particular focus on understanding the role of the placenta and its hormones in mediating both maternal and offspring disease. He is most recognised for his research investigating how maternal stress, thyroid dysfunction, hypoxia or altered nutrition affect placental development and program disease in the mother after pregnancy as well as her offspring. Dr Cuffe has an exceptional track record and is excited to take new honours and PhD students into his research laboratory.

I graduated with Honours in Medicine from the University of the West Indies, Jamaica, in 1992. In 1997 I relocated to the UK where I specialised in Obstetrics & Gynaecology and was admitted as a Member of the Royal College of Obstetricians & Gynaecologists in 1999. In 2012 I gained dual accreditation as a Subspecialist in Reproductive Medicine & Surgery and was admitted to the European Specialist Register. In 2012, I was appointed Senior Lecturer and Consultant in Reproductive Medicine & Surgery at University College London (UCL) and UCL Hospitals where I was the clinical lead for IVF and Recurrent Miscarriage and the scientific lead for Mammalian Oocyte Research within UCL’s Institute for Women’s Health. In January 2014 I relocated to Australia after being recruited to UNSW through the DVCR’s Strategic Priority Funding Scheme. At UNSW I jointly set up and co-directed UNSW’s first oocyte biology research lab. In January 2016, following a competitive global search, I was appointed to the fully endowed Christopher Chen Chair in Reproductive Medicine at UQ where I currently head the Christopher Chen Oocyte Research Laboratory. Since relocating to Australia I have been awarded Fellowship of the Royal Australian NZ College of Obstetricians & Gynaecologists.

In parallel with clinical activity, I have developed an internationally leading research program investigating oocyte maturation and oocyte quality. My Ph.D was awarded in 2009 from the University of Newcastle-upon-Tyne (UK) and received a Dean’s commendation. My thesis investigated the regulation of chromosome segregation in mouse and human oocytes and was funded by a WellBeing of Women Research Training Fellowship. My post-doctoral research was undertaken at UCL funded by a prestigious Wellcome Trust Clinician Scientist Fellowship ($1.2 million). At UCL, I was one of the principal investigators in the cross-faculty Mammalian Oocyte and Embryo Research Laboratory. In my first 2 years in Australia, I have secured NHMRC funding as CIA worth over $1 million.

I have placed leading papers on oocyte regulation in high impact journals such as Science, Developmental Cell, Genes & Development and Nature Cell Biology all of which have been cited by the Faculty of 1000 Experts. I have received numerous prizes and awards including the highly prestigious Medical Research Society Young Investigator Award (first and only award made to the specialty of O&G in the UK) and was the first of the UK Walport Clinical Lecturers in all specialties to attain Clinician Scientist status. I was one of the very few to have delivered the RCOG’s William Blair Bell Memorial Lecture whilst still a clinical trainee.

Treasure McGuire graduated with a Bachelor of Pharmacy and a Bachelor of Science (Pharmacology) from the University of Queensland UQ). She also completed a Postgraduate Diploma in Clinical Pharmacy and Graduate Certificate in Higher Education at UQ. In 2005, she completed her PhD in the School of Population Health, UQ, entitled Consumer medicines call centres: a medication liaison model of pharmaceutical care.

She has held a sennior conjoint appointment between the School of Pharmacy, UQ and Mater Pharmacy, Mater Health, Brisbane since 1996, and was appointed as a Senior Lecturer in 2006. In her Mater role, she has been Assistant Director of Pharmacy (Practice and Development) over this same time period. At UQ, she coordinates a graduate clinical pharmacy course within the Master of Clinical Pharmacy program. In 2016, this program received a UQ Faculty of Health and Behavioural Sciences Team Award for Programs that Enhance Learning and in 2017 a citation in the University of Queensland Award for Excellence in Teaching and Learning.

Treasure’s research is translational, focussing on patient centred-care and quality use of medicines in the domains of medicines information, evidence-based practice, medication safety, reproductive health, complementary medicines, communicable diseases and interprofessional education. She is a Fellow of the Australian College of Pharmacy and a Fellow of the Pharmaceutical Society of Australia.In recognition of her services to medicines information, she received the Lilly International Fellowship in Hospital Pharmacy and the Bowl of Hygeia of the Pharmaceutical Society of Australia. In 2015, she was the recipient of the Sr Eileen Pollard Medal (Mater Research-UQ) for excellence in incorporating research into clinical care provision.

My research vision is to raise awareness across our society regarding the potential impacts of prenatal alcohol exposure and the whole-body condition of fetal alcohol spectrum disorder (FASD). First to support the prevention of prenatal alcohol exposure through increased access to reproductive health care and reductions in alcohol use. Second, for those who are already affected, I want to increase the availability of assessment and diagnostic services and ensure that all children, young people, and their families can have access to the supports that they need.

Dr Nicole Warrington is a NHMRC Emerging Leadership Fellow at the University of Queensland Institute for Molecular Bioscience. She has a strong background in statistical genetics and has been actively working towards understanding the genetic determinants of early life growth. Dr Warrington studied a Bachelor of Science at Victoria University in Wellington, New Zealand, majoring in Mathematical Statistics and Psychology. She then completed an honours degree at The University of Western Australia, where she developed a keen interest for genetics, and was subsequently awarded an Australian Postgraduate Award to complete her PhD in statistical genetics and life-course epidemiology. During her PhD she spent time at the University of Toronto to gain experience in statistical modelling methods for longitudinal growth trajectories and conducted the first genome-wide association study of longitudinal growth trajectories over childhood. After completing her PhD, Dr Warrington started at the University of Queensland and focused on using genetics to inform about the relationship between birth weight and cardio-metabolic diseases in later life. She pioneered a new statistical method to partition genetic effects on birth weight into maternal and fetal components, and combined this method with a causal modelling approach, Mendelian randomization. This method was instrumental in demonstrating the relationship between birth weight and adult hypertension is driven by genetic effects, over-turning 30 years of research into the effects of intrauterine programming. More recently, her research focus has broadened to determine whether rapid weight growth across early life, including fetal development, childhood and adolescence, causally increases risk of cardio-metabolic disease and in doing so, hopes to identify optimal times across the life-course where interventions could reduce the incidence of cardio-metabolic diseases.